Cargando…

A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure

We aimed to develop a prediction model based on the PIRO concept (Predisposition, Injury, Response and Organ failure) for patients with Hepatitis B Virus (HBV) related acute-on-chronic liver failure (ACLF). 774 patients with HBV related ACLF defined in the CANONIC study were analyzed according to PI...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fangfang, Zou, Zhengsheng, Shen, Lijun, Wu, Weiwei, Luo, Jiajun, Lankford, Seth, Yang, Yongli, Huang, Huang, You, Shaoli, Zhu, Bing, Li, Jin, Mu, Jinsong, Zhang, Yawei, Xin, Shaojie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677318/
https://www.ncbi.nlm.nih.gov/pubmed/33214662
http://dx.doi.org/10.1038/s41598-020-77235-3
_version_ 1783611945859940352
author Liu, Fangfang
Zou, Zhengsheng
Shen, Lijun
Wu, Weiwei
Luo, Jiajun
Lankford, Seth
Yang, Yongli
Huang, Huang
You, Shaoli
Zhu, Bing
Li, Jin
Mu, Jinsong
Zhang, Yawei
Xin, Shaojie
author_facet Liu, Fangfang
Zou, Zhengsheng
Shen, Lijun
Wu, Weiwei
Luo, Jiajun
Lankford, Seth
Yang, Yongli
Huang, Huang
You, Shaoli
Zhu, Bing
Li, Jin
Mu, Jinsong
Zhang, Yawei
Xin, Shaojie
author_sort Liu, Fangfang
collection PubMed
description We aimed to develop a prediction model based on the PIRO concept (Predisposition, Injury, Response and Organ failure) for patients with Hepatitis B Virus (HBV) related acute-on-chronic liver failure (ACLF). 774 patients with HBV related ACLF defined in the CANONIC study were analyzed according to PIRO components. Variables associated with mortality were selected into the prediction model. Based on the regression coefficients, a score for each PIRO component was developed, and a classification and regression tree was used to stratify patients into different nodes. The prediction model was then validated using an independent cohort (n = 155). Factors significantly associated with 90-day mortality were: P: age, gender and ACLF type; I: drug, infection, surgery, and variceal bleeding; R: systemic inflammatory response syndrome (SIRS), spontaneous bacteria peritonitis (SBP), and pneumonia; and O: the CLIF consortium organ failure score (CLIF-C OFs). The areas under the receiver operating characteristics curve (95% confidence interval) for the combined PIRO model for 90-day mortality were 0.77 (0.73–0.80). Based on the scores for each of the PIRO components and the cut-offs estimated from the classification and regression tree, patients were stratified into different nodes with different estimated death probability. Based on the PIRO concept, a new prediction model was developed for patients with HBV related ACLF, allowing stratification into different clusters using the different scores obtained in each PIRO component. The proposed model will likely help to stratify patients at different risk, defining individual management plans, assessing criteria for specific therapies, and predicting outcomes.
format Online
Article
Text
id pubmed-7677318
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-76773182020-11-23 A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure Liu, Fangfang Zou, Zhengsheng Shen, Lijun Wu, Weiwei Luo, Jiajun Lankford, Seth Yang, Yongli Huang, Huang You, Shaoli Zhu, Bing Li, Jin Mu, Jinsong Zhang, Yawei Xin, Shaojie Sci Rep Article We aimed to develop a prediction model based on the PIRO concept (Predisposition, Injury, Response and Organ failure) for patients with Hepatitis B Virus (HBV) related acute-on-chronic liver failure (ACLF). 774 patients with HBV related ACLF defined in the CANONIC study were analyzed according to PIRO components. Variables associated with mortality were selected into the prediction model. Based on the regression coefficients, a score for each PIRO component was developed, and a classification and regression tree was used to stratify patients into different nodes. The prediction model was then validated using an independent cohort (n = 155). Factors significantly associated with 90-day mortality were: P: age, gender and ACLF type; I: drug, infection, surgery, and variceal bleeding; R: systemic inflammatory response syndrome (SIRS), spontaneous bacteria peritonitis (SBP), and pneumonia; and O: the CLIF consortium organ failure score (CLIF-C OFs). The areas under the receiver operating characteristics curve (95% confidence interval) for the combined PIRO model for 90-day mortality were 0.77 (0.73–0.80). Based on the scores for each of the PIRO components and the cut-offs estimated from the classification and regression tree, patients were stratified into different nodes with different estimated death probability. Based on the PIRO concept, a new prediction model was developed for patients with HBV related ACLF, allowing stratification into different clusters using the different scores obtained in each PIRO component. The proposed model will likely help to stratify patients at different risk, defining individual management plans, assessing criteria for specific therapies, and predicting outcomes. Nature Publishing Group UK 2020-11-19 /pmc/articles/PMC7677318/ /pubmed/33214662 http://dx.doi.org/10.1038/s41598-020-77235-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Liu, Fangfang
Zou, Zhengsheng
Shen, Lijun
Wu, Weiwei
Luo, Jiajun
Lankford, Seth
Yang, Yongli
Huang, Huang
You, Shaoli
Zhu, Bing
Li, Jin
Mu, Jinsong
Zhang, Yawei
Xin, Shaojie
A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure
title A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure
title_full A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure
title_fullStr A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure
title_full_unstemmed A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure
title_short A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure
title_sort prediction model for outcome in patients with hbv-aclf based on predisposition, injury, response and organ failure
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677318/
https://www.ncbi.nlm.nih.gov/pubmed/33214662
http://dx.doi.org/10.1038/s41598-020-77235-3
work_keys_str_mv AT liufangfang apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT zouzhengsheng apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT shenlijun apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT wuweiwei apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT luojiajun apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT lankfordseth apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT yangyongli apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT huanghuang apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT youshaoli apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT zhubing apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT lijin apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT mujinsong apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT zhangyawei apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT xinshaojie apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT liufangfang predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT zouzhengsheng predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT shenlijun predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT wuweiwei predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT luojiajun predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT lankfordseth predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT yangyongli predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT huanghuang predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT youshaoli predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT zhubing predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT lijin predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT mujinsong predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT zhangyawei predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure
AT xinshaojie predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure